UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Development and validation of an automated system for assessment of liver steatosis and fibrosis in routine histological images in patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2017, Vol.66 (1), p.S589-S590

2017

Volltextzugriff (PDF)

The severity of steatosis does not influence liver stiffness measurements in patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2017, Vol.66 (1), p.S586-S587

2017

Volltextzugriff (PDF)

Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review

Human reproduction (Oxford), 2007-02, Vol.22 (2), p.313-316

2007

Volltextzugriff (PDF)

P0497 : Secretory leukocyte protease inhibitor (SLPI) suppresses innate immune responses and promotes resolution of inflammation in an auto/paracrine manner during acute liver failure (ALF)

Journal of hepatology, 2015-04, Vol.62, p.S500-S501

2015

Volltextzugriff (PDF)

1325 RIFAXIMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL PILOT STUDY

Journal of hepatology, 2013-04, Vol.58, p.S534-S535

2013

Volltextzugriff (PDF)

355 IS OIL RED-O AND DIGITAL IMAGE ANALYSIS THE GOLD STANDARD FOR QUANTIFYING STEATOSIS IN THE LIVER?

Journal of hepatology, 2010, Vol.52, p.S147-S148

2010

Volltextzugriff (PDF)

887 A NOVEL MOUSE MODEL OF HEPATIC GLYCOGEN STORAGE DISEASE TYPE 3 IDENTIFIED USING A PHENOTYPE-DRIVEN ETHYL-NITROSOUREA (ENU) MUTAGENESIS SCREEN

Journal of hepatology, 2011-03, Vol.54, p.S353-S353

2011

Volltextzugriff (PDF)

96 VANIN-1 ACTIVITY MODULATES THE STEATOSISSTEATOHEPATITIS TRANSITION IN PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS

Journal of hepatology, 2011-03, Vol.54, p.S42-S43

2011

Volltextzugriff (PDF)

802 CELL SURFACE PANTETHEINASE, VANIN-1, INCREASES OXIDATIVE DAMAGE IN ACETAMINOPHEN INDUCED LIVER INJURY VIA A REDUCTION IN GLUTATHIONE

Journal of hepatology, 2010, Vol.52, p.S311-S312

2010

Volltextzugriff (PDF)

395 NON-INVASIVE ASSESSMENT OF HEPATIC LIPID COMPOSITION: LIPID POLYUNSATURATION DECREASES WITH INCREASING FIBROSIS IN CHRONIC HEPATITIS C

Journal of hepatology, 2009, Vol.50, p.S149-S150

2009

Volltextzugriff (PDF)

Prospective evaluation of screening strategies for NAFLD in people with type-2 diabetes mellitus in the community

Digestive and liver disease, 2023-03, Vol.55, p.S17-S18

2023

Volltextzugriff (PDF)

[328] PAR-1 KNOCKOUT BONE MARROW STEM CELLS CAN CONFER AN ANTI-FIBROTIC PHENOTYPE TO THE INJURED LIVER

Journal of hepatology, 2007, Vol.46, p.S129-S129

2007

Volltextzugriff (PDF)

[702] CAN DISEASE PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE BE PREDICTED BY METABOLIC BIOMARKERS OF LIPID ACCUMULATION AND PEROXIDATION?

Journal of hepatology, 2007, Vol.46, p.S265-S265

2007

Volltextzugriff (PDF)

Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects

Molecular oncology, 2014-02, Vol.8 (1), p.39-49

2014

Volltextzugriff (PDF)

726 EARLY HAEMODYNAMIC RESPONSES TO INTERFERON THERAPY IN PATIENTS WITH CHRONIC LIVER DISEASE USING CONTRAST-ENHANCED ULTRASOUND: REGULATION BY HEPATIC STELLATE CELLS?

Journal of hepatology, 2008, Vol.48, p.S271-S271

2008

Volltextzugriff (PDF)

Lipofuscin is detected in early stages of the disease in liver biopsies of patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2018-04, Vol.68, p.S819

2018

Volltextzugriff (PDF)

The pathogenic role of Stat2 in inflammation is independent of canonical interferon signaling and is mediated by TNFa

Journal of hepatology, 2018-04, Vol.68, p.S612

2018

Volltextzugriff (PDF)

SAT-018 - The pathogenic role of Stat2 in inflammation is independent of canonical interferon signaling and is mediated by TNFa

Journal of hepatology, 2018-04, Vol.68, p.S612-S612

2018

Volltextzugriff (PDF)

SAT-477 - Lipofuscin is detected in early stages of the disease in liver biopsies of patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2018-04, Vol.68, p.S819-S819

2018

Volltextzugriff (PDF)

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1336-1343

2008

Volltextzugriff (PDF)

SAT-307 - Development and validation of an automated system for assessment of liver steatosis and fibrosis in routine histological images in patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2017, Vol.66 (1), p.S589-S590

2017

Volltextzugriff (PDF)

SAT-300 - The severity of steatosis does not influence liver stiffness measurements in patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2017, Vol.66 (1), p.S586-S587

2017

Volltextzugriff (PDF)

Quantitative comparison of PD-L1 immuno-histochemical assays in hepatocellular carcinoma: The Blueprint-HCC study

Journal of hepatology, 2018-04, Vol.68, p.S669

2018

Volltextzugriff (PDF)

SAT-142 - Quantitative comparison of PD-L1 immuno-histochemical assays in hepatocellular carcinoma: The Blueprint-HCC study

Journal of hepatology, 2018-04, Vol.68, p.S669-S669

2018

Volltextzugriff (PDF)

GRANULOMAS AND HEPATITIS C

Histopathology, 1996-03, Vol.28 (3), p.265-267

1996

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development and validation of an automated system for assessment of liver steatosis and fibrosis in routine histological images in patients with Non-Alcoholic Fatty Liver Disease

The severity of steatosis does not influence liver stiffness measurements in patients with Non-Alcoholic Fatty Liver Disease

Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review

P0497 : Secretory leukocyte protease inhibitor (SLPI) suppresses innate immune responses and promotes resolution of inflammation in an auto/paracrine manner during acute liver failure (ALF)

1325 RIFAXIMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL PILOT STUDY

355 IS OIL RED-O AND DIGITAL IMAGE ANALYSIS THE GOLD STANDARD FOR QUANTIFYING STEATOSIS IN THE LIVER?

887 A NOVEL MOUSE MODEL OF HEPATIC GLYCOGEN STORAGE DISEASE TYPE 3 IDENTIFIED USING A PHENOTYPE-DRIVEN ETHYL-NITROSOUREA (ENU) MUTAGENESIS SCREEN

96 VANIN-1 ACTIVITY MODULATES THE STEATOSISSTEATOHEPATITIS TRANSITION IN PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS

802 CELL SURFACE PANTETHEINASE, VANIN-1, INCREASES OXIDATIVE DAMAGE IN ACETAMINOPHEN INDUCED LIVER INJURY VIA A REDUCTION IN GLUTATHIONE

395 NON-INVASIVE ASSESSMENT OF HEPATIC LIPID COMPOSITION: LIPID POLYUNSATURATION DECREASES WITH INCREASING FIBROSIS IN CHRONIC HEPATITIS C

Prospective evaluation of screening strategies for NAFLD in people with type-2 diabetes mellitus in the community

[328] PAR-1 KNOCKOUT BONE MARROW STEM CELLS CAN CONFER AN ANTI-FIBROTIC PHENOTYPE TO THE INJURED LIVER

[702] CAN DISEASE PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE BE PREDICTED BY METABOLIC BIOMARKERS OF LIPID ACCUMULATION AND PEROXIDATION?

Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects

726 EARLY HAEMODYNAMIC RESPONSES TO INTERFERON THERAPY IN PATIENTS WITH CHRONIC LIVER DISEASE USING CONTRAST-ENHANCED ULTRASOUND: REGULATION BY HEPATIC STELLATE CELLS?

Lipofuscin is detected in early stages of the disease in liver biopsies of patients with Non-Alcoholic Fatty Liver Disease

The pathogenic role of Stat2 in inflammation is independent of canonical interferon signaling and is mediated by TNFa

SAT-018 - The pathogenic role of Stat2 in inflammation is independent of canonical interferon signaling and is mediated by TNFa

SAT-477 - Lipofuscin is detected in early stages of the disease in liver biopsies of patients with Non-Alcoholic Fatty Liver Disease

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

SAT-307 - Development and validation of an automated system for assessment of liver steatosis and fibrosis in routine histological images in patients with Non-Alcoholic Fatty Liver Disease

SAT-300 - The severity of steatosis does not influence liver stiffness measurements in patients with Non-Alcoholic Fatty Liver Disease

Quantitative comparison of PD-L1 immuno-histochemical assays in hepatocellular carcinoma: The Blueprint-HCC study

SAT-142 - Quantitative comparison of PD-L1 immuno-histochemical assays in hepatocellular carcinoma: The Blueprint-HCC study

GRANULOMAS AND HEPATITIS C

Suchergebnisse filtern